Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Democratic-led U.S. House panel opposes any U.S. trade deal with Brazil

Published 06/03/2020, 04:28 PM
Updated 06/03/2020, 05:40 PM
© Reuters. House Ways and Means Committee Chairman Neal discusses request for copies of President Donald Trump's tax returns at Capitol in Washington

WASHINGTON (Reuters) - The U.S. House Ways and Means Committee said on Wednesday it opposed the Trump administration's plan to expand economic ties with Brazil given its record on human rights and the environment under President Jair Bolsonaro.

Committee Chairman Richard Neal and his fellow Democrats on the panel told U.S. Trade Representative Robert Lighthizer in a letter that Bolsonaro's government had shown a "complete disregard for basic human rights."

"We strongly oppose pursuing any type of trade agreement with the Bolsonaro government in Brazil. Enhancing the U.S.-Brazilian economic relationship at this time would undermine the efforts of Brazilian human, labor, and environmental rights advocates to advance the rule of law and protect and preserve marginalized communities," they wrote.

U.S. and Brazilian trade officials agreed last month to accelerate talks aimed at concluding an agreement on trade rules and transparency this year, including trade facilitation and "good regulatory practices."

But Democrats on the committee said Bolsonaro's government could not credibly be prepared to assume new standards for worker rights and environmental protections established in the U.S.-Mexico-Canada trade agreement, given its own poor record on human rights and other key issues.

Representative Kevin Brady (NYSE:BRC), the ranking Republican on the committee, told reporters he was unaware of the letter.

Instead of pursuing a trade agreement with Brazil, the Democratic lawmakers said Lighthizer should step up enforcement of U.S. laws and raise concerns about Brazil's unfair trade practices with the Brazilian government.

U.S. President Donald Trump has developed a close relationship Bolsonaro, a right-wing former army captain. The White House last week said the United States had supplied Brazil with 2 million doses of hydroxychloroquine for use against the coronavirus, despite medical warnings about risks associated with the anti-malaria drug.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

I bet that if it was the Worker's Party who won the 2018 election, this comitee would be fine to make commercial agreements in "complete disregard" for the billions in kickbacks stolen from Brazilians in the last 16 years by those leftists.
Dems love treaties with China but they are scared about Bolsonaro. they must go this November
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.